According to its website, the Menlo Park–based firm got its name because its “co-founders believed a simple blood test could ...

An mRNA cancer vaccine quickly reprogrammed the immune system to attack the most aggressive type of brain tumor in a first-ever human clinical trial.

The Proton Clinical Research Center at Shandong Cancer Hospital affiliated with Shandong First Medical University has ...

Malignant melanoma is the fastest-growing and 7th most frequent cancer in the United States (Swetter, 2003). Its incidence has tripled among Caucasians over the last 40 years (Pockaj et al., ...

May marks Skin Cancer Awareness Month, drawing attention to the disease’s prevalence, with over five million cases identified annually in the United States. Residing in Northern Nevada presents a ...

St. Jude Children's Research Hospital scientists reversed an aggressive cancer, reverting malignant cells towards a more normal state. Rhabdoid tumors are an aggressive cancer which is missing a ...

In a recent study published in the journal Nature Medicine, a European team of researchers quantitatively characterized the ...

Uruguay’s leftist ex-leader Jose Mujica, once known as the world's "poorest president" for giving away most of his salary and ...

Clinical Features. Basal cell carcinoma (BCC) is the most common malignant eyelid tumor, accounting for 85% of all such tumors. [1] The tumor usually affects adults but may also occur in younger ...

New mRNA Cancer Vaccine Triggers Fierce Immune Response to Fight Malignant Brain Tumor May 1, 2024 — An mRNA cancer vaccine quickly reprogrammed the immune system to attack the most aggressive ...

Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set statistic alerts) please log in with your personal ...